Literature DB >> 27347008

Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Songsak Kiatchoosakun1, Chaiyasith Wongwipaporn1, Burabha Pussadhamma1.   

Abstract

BACKGROUND: The prognostic factors of in-hospital mortality in all comers and unselected patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) have not been well established.
OBJECTIVE: To identify the predictive factors of in-hospital mortality in patients with STEMI undergoing primary PCI in a tertiary heart centre.
METHODS: Between January 2008 and December 2011, all patients with STEMI undergoing primary PCI were retrospectively included in this study. Baseline characteristics and angiographic data were reviewed and recorded. The study endpoint was all-cause in-hospital mortality.
RESULTS: Of the 541 patients included in the study, 63 (11.6%) died during hospitalisation. Cardiogenic shock at admission was recorded in 301 patients (55.6%) and 424 patients (78%) had multivessel disease. Median door-to-device time was 65 min. After adjustment for baseline variables, the factors associated with in-hospital mortality included age >60 years (OR 2.98, 95% CI 1.17 to 7.05; p=0.01), left ventricular ejection fraction <40% (OR 2.53, 95% CI 1.20 to 5.36; p=0.02), and final TIMI flow grade 0/1 (OR 20.55, 95% CI 3.49 to 120.94; p=0.001).
CONCLUSIONS: Age, left ventricular function and final TIMI flow are significant predictors of adverse outcomes in unselected patients with STEMI undergoing primary PCI.

Entities:  

Keywords:  INTERVENTIONAL CARDIOLOGY; MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)

Year:  2016        PMID: 27347008      PMCID: PMC4916565          DOI: 10.1136/heartasia-2015-010715

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  30 in total

1.  Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).

Authors:  Sorin J Brener; Roxana Mehran; Bruce R Brodie; Giulio Guagliumi; Bernhard Witzenbichler; Ecaterina Cristea; Ke Xu; Alexandra J Lansky; Gregg W Stone
Journal:  Am J Cardiol       Date:  2011-07-20       Impact factor: 2.778

2.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

3.  Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.

Authors:  Amir Halkin; Mandeep Singh; Eugenia Nikolsky; Cindy L Grines; James E Tcheng; Eulogio Garcia; David A Cox; Mark Turco; Thomas D Stuckey; Yingo Na; Alexandra J Lansky; Bernard J Gersh; William W O'Neill; Roxana Mehran; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

4.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

5.  Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).

Authors:  Henning Rud Andersen; Torsten Toftegaard Nielsen; Thomas Vesterlund; Peer Grande; Ulrik Abildgaard; Per Thayssen; Flemming Pedersen; Leif Spange Mortensen
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

6.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

Review 7.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

8.  Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Paul Sorajja; Bernard J Gersh; David A Cox; Michael G McLaughlin; Peter Zimetbaum; Costantino Costantini; Thomas Stuckey; James E Tcheng; Roxana Mehran; Alexandra J Lansky; Cindy L Grines; Gregg W Stone
Journal:  Eur Heart J       Date:  2007-06-07       Impact factor: 29.983

9.  Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study.

Authors:  G Sanz; A Castañer; A Betriu; J Magriña; E Roig; S Coll; J C Paré; F Navarro-López
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

10.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  1 in total

1.  Prevalence and predictors associated with in-hospital mortality in acute ST segment elevation myocardial infarction after reperfusion therapy in developing country.

Authors:  Chorchana Wichian; Thotsaporn Morasert; Thanapon Nilmoje; Ply Chichareon
Journal:  Cardiovasc Diagn Ther       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.